Sign In
Buy EGRX
$0.460
+0 (+0%)
At Close: Jun 03, 2026
Critical Contrast: Eagle Pharmaceuticals (NASDAQ:EGRX) & Indivior (OTCMKTS:INVVY)
01:44am, Friday, 17'th Apr 2026
Eagle Pharmaceuticals (NASDAQ: EGRX - Get Free Report) and Indivior (OTCMKTS:INVVY - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesse
Did Eagle Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
05:38pm, Thursday, 09'th Apr 2026
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible
Eagle Pharmaceuticals (NASDAQ:EGRX) Shares Pass Above 50-Day Moving Average – Should You Sell?
03:13am, Tuesday, 31'st Mar 2026
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX - Get Free Report) shares passed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $0.26 and traded as high a
Eagle Pharmaceuticals Announces Divestiture of Barhemsys
10:21am, Wednesday, 14'th Jan 2026
WOODCLIFF LAKE, N.J., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased to announce the divestiture of the marketing authoriza
Eagle Pharmaceuticals (NASDAQ:EGRX) Shares Pass Below Fifty Day Moving Average – Here’s What Happened
04:24am, Friday, 09'th Jan 2026
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX - Get Free Report) passed below its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $0.65 and traded as low a
Aadi Bioscience (NASDAQ:AADI) vs. Eagle Pharmaceuticals (NASDAQ:EGRX) Head to Head Survey
02:10am, Sunday, 04'th Jan 2026
Risk and Volatility Eagle Pharmaceuticals has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Aadi Bioscience has a beta of 0.68, meaning that its sh
HALPER SADEH LLC ENCOURAGES EAGLE PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
12:30pm, Wednesday, 24'th Dec 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK , Dec. 24, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investi
Halper Sadeh LLC Encourages Eagle Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights
03:12pm, Sunday, 07'th Dec 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Eagle Pharmaceuticals, Inc. (OTCPK: EGRX) breached their fiduciary
Eagle Pharmaceuticals (NASDAQ:EGRX) Stock Price Passes Below 200 Day Moving Average – What’s Next?
03:44am, Saturday, 22'nd Nov 2025
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX - Get Free Report) crossed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $2.48 and traded as low as $0.
Eagle Pharmaceuticals Announces Availability of Unaudited Second Quarter 2025 Financial Statements
04:30pm, Wednesday, 15'th Oct 2025
WOODCLIFF LAKE, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that the Company's unaudited financial statements
Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
07:30pm, Monday, 06'th Oct 2025
WOODCLIFF LAKE, N.J., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that the Company's unaudited financial statements
Eagle Pharmaceuticals Announces Availability of Proxy Materials and Audited Financial Statements for the 2023 and 2024 Fiscal Years
04:43pm, Wednesday, 17'th Sep 2025
WOODCLIFF LAKE, N.J., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced the availability of proxy materials for its 2025
Eagle Pharmaceuticals to Appoint Abhinav Jain to its Board of Directors
07:30pm, Thursday, 28'th Aug 2025
WOODCLIFF LAKE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that it has agreed to appoint Abhinav “Abi” J
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
04:30pm, Monday, 18'th Aug 2025
WOODCLIFF LAKE, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its 2025 Annual Meeting of Stockholders (the
Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan
04:30pm, Friday, 21'st Mar 2025
WOODCLIFF LAKE, N.J., March 21, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) today announced that its Board of Directors (the “Board”) ha
